*Articles from the former Asklep
ASKLEP Inc., a Japan based CRO providing clinical research services and XClinical, a European vendor of innovative software products for e-clinical trials, today announced the signing of a Strategic Marketing and Partnership Agreement giving ASKLEP distribution exclusivity rights for MARVIN in Japan.The two companies will be exhibiting together at the CDISC Conference in Tokyo June 5th and 6th.
Takenori Ogawa, the President of ASKLEP said, “ASKLEP and XClinical have been working together very closely over the last few months jointly developing the Japanese version of MARVIN. We are extremely pleased to partner with XClinical and we are excited to be able to offer such a robust and sophisticated EDC system to the Japanese Market”.
“This partnership is an important step in our strategy to collaborate with very professional local partners for delivering our applications and related services worldwide”, says Dr. Claus Lindenau, Head of Business Development at XClinical. “A thorough understanding of the market needs, culture, language as well as a strong basis of existing business relationships are essential to be successful in the Asian market. Asklep, with its long and successful history in Japan, is a perfect partner for us!”
Asklep, Inc., (http://www.asklep.co.jp) founded in 1992, in Tokyo, Japan, provides clinical research services in monitoring, data management, biostatistics, regulatory & consulting, CRA training, etc. ASKLEP is an INTAGE Group Company. INTAGE, INC., (http://www.intage.co.jp) is the largest marketing research company in Japan and the eleventh largest globally. It has one of the most comprehensive healthcare solution services in the industry
About XClinical GmbH
XClinical GmbH (www.xclinical.com), an innovative EDC-CDM system vendor based in Munich, Paris and Boston, USA, provides solutions for the electronic conduct of all types of clinical trials, post-marketing studies and registries.XClinical develops and markets MARVIN, a CDISC ODM certified online platform for Electronic Data Capture (EDC), Clinical Data Management (CDM) and Clinical Trial Management (CTM). Till today, MARVIN was used to collect and process data of more than 50,000 patients in 50+ studies.